Medifast MED Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70.1%-1.2pp | 71.3%-1.1pp | 72.4%-1.4pp | 73.8%0.0pp | 73.9%+0.1pp | |
| Operating margin | -4.7%-1.0pp | -3.7%-2.4pp | -1.3%-1.4pp | 0.1%+1.3pp | -1.2%-1.6pp | |
| Net margin | -5.8%-0.9pp | -4.8%-4.9pp | 0.1%-0.7pp | 0.8%+2.0pp | -1.3%-1.6pp | |
| EBITDA margin | -0.5%-0.5pp | 0%-1.9pp | 1.9%-1.0pp | 3%+1.8pp | 1.2%-1.4pp | |
| Returns | ||||||
| Return on equity | -9.8%-0.7pp | -9.1%-9.2pp | 0.1%-1.6pp | 1.7%+5.0pp | -3.3%-4.3pp | |
| Return on assets | -7.5%-0.5pp | -7%-7.1pp | 0.1%-1.2pp | 1.3%+3.7pp | -2.4%-3.1pp | |
| Return on invested capital | -11.8%-0.6pp | -11.1%-8.7pp | -2.4%-2.6pp | 0.2%+5.0pp | -4.7%-5.9pp | |
| Efficiency | ||||||
| Asset turnover | 1.3×-0.1× | 1.4×-0.1× | 1.5×-0.2× | 1.7×-0.2× | 1.9×-0.2× | |
| Inventory turnover | 3.4×-0.1× | 3.5×-0.2× | 3.7×+0.1× | 3.6×+0.3× | 3.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 4.8×+0.1× | 4.7×+0.2× | 4.4×0.0× | 4.5×+0.9× | 3.5×+0.2× | |
| Quick ratio | 4.3×+0.1× | 4.2×+0.3× | 4×+0.1× | 3.8×+0.9× | 2.9×+0.2× | |
| Cash ratio | 1.7×-0.4× | 2.1×-0.1× | 2.1×-0.1× | 2.2×+0.7× | 1.5×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $17.96-0.8% | $18.11-7.3% | $19.530.0% | $19.53+1.4% | $19.27+0.5% | |
| Valuation | ||||||
| Market capitalization | $121.87M-17.4% | $117.39M-21.9% | $150.25M-0.2% | $150.58M+2.1% | $147.44M-23.5% | |
| Enterprise value | $66.44M+12.8% | $38.78M-38.4% | $62.98M+1.7% | $61.95M-11.9% | $70.33M-40.4% | |
| Price / sales | 0.4×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Price / book | 0.6×-0.1× | 0.6×-0.1× | 0.7×0.0× | 0.7×0.0× | 0.7×-0.2× | |
| EV / sales | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | |
| Earnings yield | -16.4%-18.9pp | -15.9%-16.1pp | 0.2%-2.3pp | 2.4%+7.2pp | -4.7%-5.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Medifast's profit margins?
- Medifast (MED) runs a 70.1% gross margin and a -4.7% operating margin, with a -5.8% net margin.
- Where do Medifast's ratios come from?
- Every ratio is computed from Medifast's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
